https://www.fool.com/investing/general/2015/10/24/valeant-pharmaceuticals-posts-strong-q3-results.aspx
Valeant Pharmaceuticals Posts Strong Q3 Results | The Motley Fool
Oct 24, 2015 - Solid organic growth helps the drugmaker beat expectations in the third quarter.
valeant pharmaceuticalsthe motleypostsstrongq3
https://www.fool.com/investing/general/2015/10/30/why-valeant-pharmaceuticals-intl-inc-tumbled-again.aspx
Why Valeant Pharmaceuticals Intl Inc Tumbled Again Today | The Motley Fool
Oct 30, 2015 - More issues with its associated specialty pharmacy, Philidor.
valeant pharmaceuticalsthe motleyintlinc
https://www.newswire.ca/news-releases/valeant-pharmaceuticals-to-announce-2012-fourth-quarter-results-on-february-28-2013-511904601.html
Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
/CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...
valeant pharmaceuticalsto announcefourth quarter
https://investingnews.com/tag/valeant-pharmaceuticals
valeant pharmaceuticals | INN
valeant pharmaceuticalsinn
https://www.prnewswire.com/news/valeant-pharmaceuticals-international%2C-inc./?page=2&pagesize=25
Valeant Pharmaceuticals International, Inc. News and Press Releases | PR Newswire
news and press releasesvaleant pharmaceuticalsinternationalincnewswire
https://www.payscale.com/research/AE/Employer=Valeant_Pharmaceuticals/Hourly_Rate
Valeant Pharmaceuticals Hourly Pay in United Arab Emirates in 2026 | PayScale
Valeant Pharmaceuticals in United Arab Emirates in 2026 - Hourly Rate - Get a free salary comparison based on job title, skills, experience and education....
united arab emiratesvaleant pharmaceuticalspay inhourly2026
https://www.ibtimes.co.uk/allergan-rejects-47bn-offer-valeant-pharmaceuticals-1448314
Allergan Rejects $47bn Offer From Valeant Pharmaceuticals | IBTimes UK
May 13, 2014 - Proposal substantially undervalued Allergan, according to company.
valeant pharmaceuticalsallerganrejectsofferibtimes
https://www.prnewswire.com/news/valeant-pharmaceuticals-international%2C-inc./?page=3&pagesize=25
Valeant Pharmaceuticals International, Inc. News and Press Releases | PR Newswire
news and press releasesvaleant pharmaceuticalsinternationalincnewswire
https://www.prnewswire.com/news/valeant-pharmaceuticals-international%2C-inc./?page=4&pagesize=25
Valeant Pharmaceuticals International, Inc. News and Press Releases | PR Newswire
news and press releasesvaleant pharmaceuticalsinternationalincnewswire
https://www.fool.com/investing/2016/07/14/why-cree-harsco-and-valeant-pharmaceuticals-jumped.aspx
Why Cree, Harsco, and Valeant Pharmaceuticals Jumped Today | The Motley Fool
Jul 14, 2016 - These stocks contributed to the market's record run. Find out why.
valeant pharmaceuticalsthe motleycreeharsco
https://www.biospace.com/the-day-in-review-valeant-pharmaceuticals-international-rises-despite-mixed-trial-results
The Day In Review: Valeant Pharmaceuticals International Rises Despite Mixed Trial Results -...
the dayin reviewvaleant pharmaceuticals
https://www.payscale.com/research/AE/Employer=Valeant_Pharmaceuticals/Reviews
Working at Valeant Pharmaceuticals in United Arab Emirates | PayScale
What's it like to work at Valeant Pharmaceuticals in United Arab Emirates? Visit PayScale to research current and former Valeant Pharmaceuticals employee...
united arab emiratesvaleant pharmaceuticalsworkingpayscale
https://www.biospace.com/valeant-pharmaceuticals-international-to-webcast-2009-annual-meeting-of-stockholders
Valeant Pharmaceuticals International to Webcast 2009 Annual Meeting of Stockholders - BioSpace
valeant pharmaceuticalsannual meetinginternationalwebcast
https://www.fool.com/investing/general/2016/05/17/why-pandora-media-southwestern-energy-and-valeant.aspx
Why Pandora Media, Southwestern Energy, and Valeant Pharmaceuticals Jumped Today | The Motley Fool
May 17, 2016 - Even though the market fell sharply today, these stocks rose. Find out why.
https://www.fool.com/investing/2018/01/05/3-compelling-reasons-valeant-pharmaceuticals-explo.aspx
3 Compelling Reasons Valeant Pharmaceuticals Exploded Higher by 24% in December | The Motley Fool
Jan 5, 2018 - Valeant took another step forward on its road to redemption, but it still has a long walk ahead.
https://www.cityam.com/valeant-pharmaceuticals-slams-scathing-note-on-drug-sales-in-bid-to-reverse-share-price-spiral/
Valeant Pharmaceuticals slams scathing note on drug sales in bid to reverse share price spiral
Oct 21, 2015 - Under fire drug company Valeant Pharmaceuticals tried to halt its plummeting share price yesterday by hitting back at a damning note that questioned the...
https://www.fool.com/investing/2017/05/04/shocker-valeant-pharmaceuticals-slides-another-16.aspx
Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here's the Big Reason Why | The...
May 4, 2017 - Despite being valued below its full-year EBITDA forecast, Valeant's debt woes continue to take center stage.
https://www.foxbusiness.com/video/4075892814001
Valeant buys Salix Pharmaceuticals for $10.1B | Fox Business Video
salix pharmaceuticalsfox businessvaleantbuys10
https://www.fool.com/investing/2016/09/09/hillary-clintons-new-prescription-drug-proposal-ta.aspx
Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan |...
Sep 9, 2016 - Clinton lays out a plan to tackle prescription drug price inflation, but will it work?
https://www.newswire.ca/news-releases/valeant-announces-sale-of-inova-pharmaceuticals-for-930-million-627196361.html
Valeant Announces Sale of iNova Pharmaceuticals for $930 Million
/CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced it has entered into an agreement to sell its iNova...
sale ofinova pharmaceuticalsvaleantannounces930
https://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-the-addition-of-three-new-independent-directors-to-its-board-300233206.html
Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Dr. Fred Eshelman, Mr. Stephen Fraidin and Mr....